Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

Abstract

This is an observational, multicenter, prospective cohort study including patients treated with CAR-T in Italian centers. Patients eligible for enrollment in the study will be consecutively included in Italian FIL centers. A longitudinal survey will be carried out by collecting patients' data before starting CAR-T (T0) and after 6 (T1), 12 (T2) and 24 (T3) months after CAR-T infusion. Status: NOT_YET_RECRUITING Conditions: Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma; Primary Mediastinal B-cell Lymphoma (PMBCL) Interventions: Chimeric Antigen Receptor T-cells (CAR-T) therapy

Keywords

Sources